Why GLP-1 drugs won’t solve the obesity epidemic
The introduction of glucagon-like peptide-1 (GLP-1) receptor agonists (Ozenpic and Wegoby) is a breakthrough in the management of obesity. These drugs have been proven to be extremely effective in promoting weight loss and improving blood sugar levels. Many people may think I have something against GLP-1, but maybe because they are a “competition” for my […]